MURA, PAOLA ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.416
EU - Europa 11.785
AS - Asia 7.854
SA - Sud America 1.129
Continente sconosciuto - Info sul continente non disponibili 328
AF - Africa 204
OC - Oceania 140
Totale 41.856
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.147
RU - Federazione Russa 3.798
IT - Italia 2.602
SG - Singapore 2.123
CN - Cina 1.835
PL - Polonia 1.261
HK - Hong Kong 1.185
IE - Irlanda 961
BR - Brasile 907
VN - Vietnam 828
SE - Svezia 753
KR - Corea 714
UA - Ucraina 689
DE - Germania 539
IN - India 375
FR - Francia 357
FI - Finlandia 328
GB - Regno Unito 247
JO - Giordania 200
CA - Canada 159
AU - Australia 138
JP - Giappone 110
TR - Turchia 93
AR - Argentina 85
BD - Bangladesh 77
ID - Indonesia 74
IQ - Iraq 56
ES - Italia 54
SC - Seychelles 48
BE - Belgio 46
MX - Messico 46
NL - Olanda 43
CI - Costa d'Avorio 36
EC - Ecuador 36
CO - Colombia 30
PK - Pakistan 29
UZ - Uzbekistan 25
ZA - Sudafrica 23
MA - Marocco 22
CH - Svizzera 21
VE - Venezuela 20
SA - Arabia Saudita 19
NG - Nigeria 16
PY - Paraguay 16
DZ - Algeria 15
PH - Filippine 15
RO - Romania 14
AZ - Azerbaigian 13
CL - Cile 12
JM - Giamaica 12
EG - Egitto 11
CR - Costa Rica 10
KZ - Kazakistan 9
LT - Lituania 9
PT - Portogallo 9
TN - Tunisia 9
KE - Kenya 8
KG - Kirghizistan 8
PE - Perù 8
TH - Thailandia 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
BO - Bolivia 7
IR - Iran 7
CZ - Repubblica Ceca 6
ET - Etiopia 6
HU - Ungheria 6
MY - Malesia 6
SV - El Salvador 6
MD - Moldavia 5
NO - Norvegia 5
NP - Nepal 5
PA - Panama 5
RS - Serbia 5
AL - Albania 4
DO - Repubblica Dominicana 4
HN - Honduras 4
OM - Oman 4
PR - Porto Rico 4
SN - Senegal 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BJ - Benin 3
BY - Bielorussia 3
DK - Danimarca 3
DM - Dominica 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
LB - Libano 3
PS - Palestinian Territory 3
QA - Qatar 3
TW - Taiwan 3
GH - Ghana 2
KW - Kuwait 2
LK - Sri Lanka 2
LV - Lettonia 2
MK - Macedonia 2
MM - Myanmar 2
Totale 41.508
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.476
Ashburn 1.757
Fairfield 1.549
Singapore 1.464
Warsaw 1.251
Jacksonville 1.021
Chandler 991
Hong Kong 961
Dublin 959
San Jose 829
Woodbridge 709
Seoul 672
Cambridge 627
Seattle 574
Houston 557
Wilmington 539
Milan 503
Los Angeles 454
Beijing 425
Hefei 396
Ann Arbor 369
Council Bluffs 362
Buffalo 308
Ho Chi Minh City 292
Princeton 283
Florence 272
Rome 258
Altamura 246
The Dalles 237
Lawrence 222
Lauterbourg 221
Boardman 201
Boston 171
Hanoi 163
Mumbai 150
Moscow 145
Melbourne 137
Medford 135
Dallas 127
New York 104
Tokyo 103
Shanghai 98
San Diego 92
Columbus 86
Munich 85
São Paulo 81
Kent 78
Helsinki 72
Naples 65
Orem 64
Paris 57
Turin 54
Da Nang 46
West Jordan 46
Frankfurt Am Main 45
Toronto 44
Bengaluru 43
Bologna 43
Brussels 43
Chicago 43
Norwalk 43
Philadelphia 43
Verona 43
Izmir 42
Auburn Hills 41
Jakarta 39
Clifton 37
Abidjan 36
Guangzhou 34
Haiphong 34
Falls Church 32
Rio de Janeiro 31
Figino 30
London 29
Hillsboro 28
Chennai 27
Brooklyn 26
Palermo 26
Baghdad 23
Denver 23
Turku 23
Belo Horizonte 22
Genoa 22
Hyderabad 22
Manchester 22
Mexico City 22
Montreal 22
Tashkent 22
Andover 21
Barcelona 21
Frankfurt am Main 21
Miano 21
Phoenix 21
Redondo Beach 20
Atlanta 19
Tianjin 19
Vancouver 19
Amsterdam 17
Catania 17
San Francisco 17
Totale 27.482
Salva come PNG Salva come JPEG
Nome #
Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state 416
Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins 382
Selection of PLA-polymers for the development of injectable prilocaine controlled release microparticles: Usefulness of thrmal analysis 366
Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-B-cyclodextrin ternary systems 339
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 336
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 318
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 301
Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide 293
Development of a new delivery system consisting in "drug-in cyclodextrin- in nanostructured lipid carriers" for ketoprofen topical delivery 289
Calcium alginate microspheres containing metformin hydrochloride niosomes and chitosomes aimed for oral therapy of type 2 diabetes mellitus 281
Amidated pectin-based wafers for econazole buccal delivery: Formulation optimization and antimicrobial efficacy estimation 250
Phase equilibria, crystallinity and dissolution rates of ibuprofen-polyethylene glycol 20000 solid dispersions 248
Solid dispersions of ibuprofen in urea. Effects of urea on dissolution 246
Bioavailability and clinical usefulness of low-strength tablets of phenytoin 239
Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen 234
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System 231
Comparative study of oxaprozin complexation with natural and chemically-modified cyclodextrins in solution and in the solid state 228
Preparation and dissolution characteristics of solid dispersions of ibuprofen in various polyethylene glycols 227
Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib 221
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin 220
CHARACTERIZATION OF THE SOLID PHASES OF PARACETAMOL AND FENAMATES AT EQUILIBRIUM IN SATURATED SOLUTIONS 218
(S)-(+)-6-Methoxy-α-methyl-2-naphtaleneacetic acid and β-cyclodextrin derivatives: inclusion in aqueous media and solid phase interaction 217
Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen 217
EFFECTS OF GRINDING WITH MICROCRYSTALLINE CELLULOSE AND CYCLODEXTRINS ON THE KETOPROFEN PHYSICOCHEMICAL PROPERTIES 216
Development and validation of a differential pulse polarographic method for quinolinic acid determination in human plasma and urine after solid-phase extraction: a chemometric approach 215
Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide, 213
Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration 210
Combined use of bile acids and aminoacids to improve permeation properties of acyclovir 209
A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption 209
ADSORPTIVE STRIPPING VOLTAMMETRY FOR THIOMERSAL ASSAY. 208
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and L-arginine aimed to improve the drug solubility 208
Advanced formulations for improving therapies with anti-inflammatory or anaesthetic drugs: A review 207
Novel Findings about Double-Loaded Curcuminin HPbcyclodextrin-in Liposomes: Effects on the Lipid Bilayer and Drug Release 207
DISSOLUTION PROPERTIES OF NAPROXEN IN COMBINATIONS WITH POLYVINYLPYRROLIDONE 206
Characterization and evaluation of the performance of different calcium and magnesium salts as excipients for direct compression 206
DIFFERENTIAL SCANNING CALORIMETRY IN COMPATIBILITY TESTING OF PICOTAMIDE WITH PHARMACEUTICAL EXCIPIENTS 201
PHYSICAL CHARACTERIZATION OF PICOTAMIDE MONOHYDRATE AND ANHYDROUS PICOTAMIDE 200
Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents 200
Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery 196
COMPARATIVE STUDY OF THE INCLUSION PROPERTIES OF BETA-CYCLODEXTRINS FOR KETOPROFEN AND IBUPROFEN IN SOLUTION AND IN THE SOLID STATE 195
In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin. 195
IMPROVEMENT OF ECONAZOLE SOLUBILITY IN MULTICOMPONENT SYSTEMS WITH CYCLODEXTRINS AND ACIDS 194
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation 194
HOW EXPERIMENTAL DESIGN CAN IMPROVE THE VALIDATION PROCESS. STUDIES IN PHARMACEUTICAL ANALYSIS. 193
Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants 193
CARBON-13 NMR STUDY OF NAPROXEN WITH CYCLODEXTRINS IN SOLUTION. 192
Analytical techniques for characterization of cyclodextrin complexes in the solid state: A review 192
Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins 192
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays 192
Taste Masking of Dexketoprofen Trometamol Orally Disintegrating Granules by High-Shear Coating with Glyceryl Distearate 191
EVALUATION OF TRANSCUTOL AS A CLONAZEPAM TRANSDERMAL PERMEATION ENHANCER FROM HYDROPHILIC GEL FORMULATIONS 191
Development and characterization of naproxen-chitosan solid systems with improved dissolution properties 191
THE PROPERTIES OF SOLID DISPERSIONS OF NAPROXEN IN VARIOUS POLYETHYLENE GLYCOLS 191
Pharmaceutical availability of digoxin tablets 189
Development and characterization of functionalized niosomes for brain targeting of dynorphin-B 187
New docking CFF91 parameters specific for cyclodextrin inclusion complexes 186
120) Effect of cyclodextrin complexation on theophylline release from coated polymeric matrix tablets 186
New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs 186
THERMAL BEHAVIOR AND DISSOLUTION PROPERTIES OF NAPROXEN FROM BINARY AND TERNARY SOLID DISPERSIONS 186
DISSOLUTION RATE AND THERMAL PROPERTIES OF NAPROXEN IN MIXTURES WITH AMORPHOUS OR CRYSTALLLINE DIMETHYL-BETACYCLODEXTRIN 185
Assessment of artificial membranes aimed for in vitro study of drug buccal permeation using experimental design 185
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles 184
INTERACTIONS OF KETOPROFEN AND IBUPROFEN WITH BETA-CYCLODEXTRINS IN SOLUTION AND IN THE SOLID STATE 184
Quality by design in the optimization of a nanosystem-ethosomal formulation for topical treatment of vitiligo 184
Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery. 183
Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting 183
THERMAL ANALYSIS OF THE DEHYDRATION PROCESS OF CROSS-LINKED POLYVINYLPYRROLIDONE AND ITS MIXTURES WITH NAPROXEN 182
Physical chemical characterization of binary systems of prilocaine hydrochloride with triacetyl-b-cyclodextrin 182
Development, characterization and in vivo evaluation of benzocaine-loaded liposomes 181
Analysis of triclosan complexes with b-ciclodextrin and its water-soluble polymeric derivative 181
Employment of indolebutyric acid and indoleacetic acids complexed with α-cyclodextrin on cuttings rooting in Olea europaea L.cv. Leccio del Corno. Effects of concentration and treatment time 181
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers 181
FORMULATION STUDIES ON TOPICAL PREPARATIONS OF CLONAZEPAM 178
Phase solubility, 1H NMR and molecular modelling studies of bupivacaine hydrochloride complexation with different cyclodextrin derivates 178
Tablets of “Hydrochlorothiazide in Cyclodextrin in Nanoclay”: A New Nanohybrid System with Enhanced Dissolution Properties 177
Response surface methodology in the optimization of chitosan-Ca pectinate bead formulations 175
Controlled-release matrix tablets of ketoprofen 174
Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated β-cyclodextrin 174
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone 174
Differential electrolytic potentiometry (DEP) with twin silver-silver sulphide membrane electrodes in micro titration of quaternary ammonium compounds 173
Development and characterization of liquisolid tablets based on mesoporous clays or silicas for improving glyburide dissolution 173
INTERACTION OF NAPROXEN WITH NONCRYSTALLINE ACETYL ß AND G-CYCLODEXTRINS IN THE SOLID AND LIQUID STATE 173
Development and ex vivo evaluation of 5-aminolevulinic acid-loaded niosomal formulations for topical photodynamic therapy 172
Development and optimization by Quality by Design strategies of frovatriptan orally disintegrating tablets for migraine management 172
Hybrid systems based on “drug – in cyclodextrin – in nanoclays” for improving oxaprozin dissolution properties 171
The influence of chitosan on cyclodextrin complexing and solubilizing abilities towards drugs 171
Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics 171
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use 170
COMPATIBILITY STUDY BETWEEN IBUPROXAM AND PHARMACEUTICAL EXCIPIENTS USING DIFFERENTIAL SCANNING CALORIMETRY, HOT-STAGE MICROCOPY AND SCANNING ELECTRON MICROSCOPY 170
CONTROLLED RELEASE MATRIX TABLETS OF KETOPROFEN. I 170
Assessment of solid state interactions of naproxen with amorphous cyclodextrin derivatives by DSC 170
Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. 170
PHASE-SOLUBILITY ANALYSIS AND MOLECULAR MODELING IN THE STUDY OF NAPROXEN-CYCLODEXTRIN INTERACTION. 169
1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with a-cyclodextrin in the presence of malic acid 169
Solubilization and interaction of naproxen with polyvinyl-pyrrolidone in aqueous solution and in the solid state 169
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 169
INFLUENCE OF THE PREPARATION METHOD ON THE PHYSICOCHEMICAL PROPERTIES OF BINARY SYSTEMS OF ECONAZOLE WITH CYCLODEXTRINS 169
Solid state characterization of glyburide-cyclodextrin co-ground products 168
Complesso di inclusione di un derivato dell'acido 4-metossii¬softalico con beta-ciclodestrina con attività antipiastrinica 168
INTERACTION OF NAPROXEN WITH CRYSTALLINE AND AMORPHOUS METHYLATED BET-CYCLODEXTRIN IN THE LIQUID AND SOLID STATE 167
Totale 20.624
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.501 0 177 133 75 52 65 79 94 80 49 265 432
2022/20234.340 417 631 153 339 399 810 579 249 537 40 127 59
2023/20241.477 92 175 264 76 75 127 39 333 26 97 99 74
2024/202511.217 354 1.112 761 1.580 3.808 1.476 149 655 435 221 379 287
2025/202612.377 1.028 1.795 1.197 1.086 1.396 417 1.263 633 1.126 545 245 1.646
2026/2027856 415 441 0 0 0 0 0 0 0 0 0 0
Totale 41.856